GASTRO-INTESTINAL CANCER

Clinical trials for GASTRO-INTESTINAL CANCER explained in plain language.

Never miss a new study

Get alerted when new GASTRO-INTESTINAL CANCER trials appear

Sign up with your email to follow new studies for GASTRO-INTESTINAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 2 Completed 1

New chemo combo shows promise for Hard-to-Treat stomach and esophageal cancers

Disease control Recruiting now

This phase II trial is testing a rotating schedule of two chemotherapy regimens (FOLFOX and FOLFIRI), with or without the immunotherapy nivolumab, in 38 people with advanced HER2-negative gastric or esophageal cancer. The goal is to see if this approach improves tumor shrinkage a…

Matched conditions: GASTRO-INTESTINAL CANCER

Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control

Last updated Jun 27, 2026 08:08 UTC

GASTRO-INTESTINAL CANCER

Get alerted when new GASTRO-INTESTINAL CANCER trials appear

New chemo combo shows promise for Hard-to-Treat stomach and esophageal cancers